Smile Digital Health Welcomes West Coast Informatics as a Certified Technology Partner, Strengthening FHIR-Centric Healthcare Interoperability

February 13, 2025 10:30 AM

Smile Digital Health, a global leader in delivering secure, standards-based healthcare data exchange solutions, is pleased to announce that West Coast Informatics (WCI) has successfully completed Smile Digital Health's Technology Partner Certification Program. This milestone underscores Smile Digital Health's unwavering commitment to enhancing healthcare interoperability and showcases WCI's dedication to powering efficient, FHIR-centered data...

Read more

Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts

February 13, 2025 9:05 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Tuesday, February 18, 2025 at the Emerging Growth Conference.Participation Instructions for Jaguar Health's Virtual Presentation at the Emerging Growth ConferenceWhen: Tuesday, February 18, 2025 from 3:55 - 4:05 PM Eastern Standard TimeWhere: Online (Click Here)Registration link for conference: Click HereReplay:...

Read more

Dr. Alexander Taghva Discusses When Spinal Cord Stimulation is a Suitable Option for Nonsurgical Back Pain Relief

February 13, 2025 9:00 AM

Chronic back pain is a common and often debilitating condition that affects millions of people worldwide. While many individuals find relief through conservative treatments such as physical therapy, medications, or injections, others continue to experience persistent pain that impacts their daily lives. For those who have exhausted nonsurgical options and wish to avoid invasive procedures, spinal cord stimulation (SCS) may be a viable solution....

Read more

Dr. Louis DeJoseph Discusses the Benefits of the QT Lift(R) for Facial and Neck Rejuvenation

February 13, 2025 9:00 AM

Facial aging can often lead to concerns like sagging skin, jowls, and loss of definition in the jawline and neck. For individuals seeking a natural-looking yet transformative solution, the QT Lift® offers a specialized approach to facial and neck rejuvenation. Developed by Dr. Louis DeJoseph, a triple board-certified facial plastic surgeon at Premier Image Cosmetic & Laser Surgery, this procedure combines advanced surgical techniques with a...

Read more

Abound Health Partners With Star Pediatrics, Expanding Into Pediatric Complex Care

February 13, 2025 9:00 AM

Abound Health announced it has entered a strategic partnership with Star Pediatrics, a leading New Jersey-based pediatric home health provider, effective February 7, 2025.This acquisition expands Abound Health's services to include pediatric patients with complex medical needs, complementing its existing IDD care services such as residential support, day programs, and behavioral health interventions."This strategic partnership marks a pivotal...

Read more

Medisafe Launches PATHWAYS: A New Tool to Help Manage the Patient Journey

February 13, 2025 8:05 AM

Medisafe, the leading digital health and patient engagement platform, is proud to announce the launch of PATHWAYS, a new, complimentary tool designed to help streamline patient tracking and enhance care coordination, especially for Alzheimer's Disease (AD) treatment.The tool helps healthcare providers (HCPs), clinics, and infusion centers efficiently manage AD patients undergoing treatment by tracking required dosing and monitoring protocols The...

Read more

Invitation to Presentation of Senzime’s Fourth Quarter 2024 Report

February 13, 2025 5:30 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2024 on February 17, 14:00 CET. The report will be published during the morning of the same day.The presentation will be held by Philip Siberg, CEO of Senzime, and after the presentation, there will be a Q&A session moderated by Erik Palin, analyst at Carnegie Investment Bank. The presentation will be held in...

Read more

Lindis Biotech and Pharmanovia Announce European Marketing Authorization Approval for Catumaxomab, A First-In-Class Treatment for Malignant Ascites

February 13, 2025 4:20 AM

LINDIS Biotech GmbH, a clinical stage biopharmaceutical company with a proprietary multi-specific antibody platform and an advanced development pipeline in immuno-oncology, and Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, today announced that catumaxomab has received marketing authorisation from the European Commission (EC), making...

Read more

Invitation to Presentation of Cantargia’s Year-End Report 2024

February 13, 2025 2:30 AM

LUND, SE / ACCESSWIRE / February 13, 2025 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) invites investors, analysts and the press to a presentation of the interim October - December and Year-End report of 2024 at 3 pm (CET) on February 21, 2025. The report will be published at 07:00 am (CET) on the same day.In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with...

Read more

Seminole, FL Dr. Esha Persad Expands Dental Care with IV Sedation Certification in Florida

February 12, 2025 8:45 PM

For many, visiting the dentist can be a stressful and overwhelming experience. From childhood traumas to health-related concerns, dental anxiety affects millions worldwide. Recognizing this critical barrier to dental care, Dr. Esha Persad-an accomplished dentist with a profound commitment to compassionate care-has recently achieved certification in IV Sedation Dentistry in Florida. This new milestone allows Dr. Persad to offer an advanced level...

Read more

Theralase(R) Demonstrates Effective Treatment of Herpes

February 12, 2025 4:15 PM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that the previous University of Manitoba research has now been validated,...

Read more

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

February 12, 2025 4:03 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced operational and financial results for the fiscal 2025 second quarter.Q2 2025 HighlightsQuarterly sequential increase in prescriptions across both portfolios, led by 29% sequential growth from the Pediatric Portfolio.Pediatric Portfolio (antihistamine franchise and pediatric multivitamin franchise)...

Read more

Nomination Committee Appointed for AGM 2025 in Ascelia Pharma AB

February 12, 2025 3:45 PM

Ascelia Pharma (STO:ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on 7 May 2025 has been appointed.In accordance with the instructions for the Nomination Committee in Ascelia Pharma, the members should be one representative of each of the three largest shareholders who wish to appoint such representative together with the chairman of the board of directors. The Nomination Committee shall...

Read more

Travel Nurses, Inc. Named a Top Workplace by the Commercial Appeal for the Fourth Consecutive Year

February 12, 2025 2:00 PM

Travel Nurses, Inc. (TNI) received a Top Workplace award for 2024 and 2025 from the Commercial Appeal. This award is based entirely on employee feedback collected through a third-party survey by Energage LLC. This is the fourth year in a row that TNI has received this prestigious award.The confidential survey uniquely measures the employee experience and its component themes, including employees feeling respected and supported, enabled to grow,...

Read more

DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health

February 12, 2025 1:45 PM

DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for positive change for the healthcare system. By fostering an inclusive, mission-driven workforce and building strong community partnerships,...

Read more

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

February 12, 2025 12:00 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its first quarter fiscal 2025 financial results after the market close on Thursday, February 13, 2025.The Company will host a conference call for shareholders and the investment community at 4:30 p.m. ET on that same day.Webcast and Conference Call Date & Time: Thursday,...

Read more

Candid Health Raises $52.5 Million Series C to Enhance GenAI Features, Expand Revenue Cycle Automation Platform to More Providers

February 12, 2025 12:00 PM

Candid Health, the autonomous revenue cycle automation platform for healthcare providers, today announced it has raised $52.5 million in Series C funding led by Oak HC/FT with participation from existing investors. This brings the company's total amount raised to $99.5 million.Providers spend more than $100 billion annually on revenue cycle management, yet today's billing requirements outpace available tooling. According to research by McKinsey,...

Read more

Puerto Rico Leads Latin America With Launch of “Caos Hormonal,” the First Spanish Edition of Dr. Terri DeNeui’s Groundbreaking Book

February 12, 2025 10:00 AM

Dr. Terri DeNeui, DNP, APRN, ACNP-BC, founder of EVEXIAS Health Solutions, recently launched the Spanish edition of her acclaimed book, "Hormone Havoc," titled "Caos Hormonal" in Spanish, in Puerto Rico. This marks the first Spanish edition of Dr. DeNeui's comprehensive guide to hormone health, making this vital and empowering knowledge now accessible to a wider audience."Caos Hormonal" addresses the complexities of hormonal imbalances and...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) CEO Confirms Sportstech Acquisition and Shares Future Acquisition Strategy at Connected: Health & Fitness Summit

February 12, 2025 9:00 AM

Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today provided shareholders with an update recapping Founder and CEO Trent Ward's appearance at the 2025 Connected: Health & Fitness Summit.For more commentary, information and details on the rationale for and structure of the acquisition, please see TRNR's shareholder update on the Company's...

Read more

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status

February 12, 2025 7:30 AM

Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, received Fast Track status from the U.S. Food and Drug Administration for eRapa, a proprietary encapsulated form of rapamycin being developed for the treatment of familial adenomatous polyposis (FAP). The news follows Biodexa reporting positive 12-month data...

Read more